ZOLL Medical Corporation (NasdaqGS: ZOLL) announced today that in a “Best of the Best” presentation at the American Heart Association Resuscitation Science Symposium in Orlando Florida, Daniel P. Davis, M.D., presented research from the University of California Resuscitation Research Center that shows a major improvement in patient outcome after cardiac arrest.
Dr. Davis stated, “Since the implementation of the program in 2007, patients at the hospital are three times more likely to survive an unexpected cardiac arrest and twice as likely to survive with good neurological outcome than was possible before this new initiative.” The program consists of a number of elements including a new and innovative Advanced Resuscitation Training program, a new and novel in-patient treatment algorithm, education, a rapid response team, and new technology to improve pre-, intra- and post- resuscitation care and process, according to Dr. Davis.
The program utilizes a number of technological innovations provided in ZOLL equipment used system-wide in the University of California San Diego Hospitals, where Dr. Davis is Director of Resuscitation. Specific capabilities of the equipment relate to monitoring and improving CPR performance and process. All of the ZOLL E Series® monitor defibrillators used for resuscitation at UCSD include Real CPR Help® real-time feedback; See Thru CPR®, industry-unique filtering technology that allows clinicians to view a patient’s underlying cardiac rhythm by filtering CPR artifact during resuscitation efforts; and sidestream and mainstream ETCO2 monitoring capability. ZOLL’s CodeNet® software collects all resuscitation and CPR process data when a resuscitation event occurs and permits the post-event review of the entire resuscitation event and process.